GS ‐9620 alleviates psoriasis‐like inflammation by regulating autophagy in keratinocytes
Animal Models and Experimental Medicine · 2026-07 · 9 (7) · 1364-1372
DOI: 10.1002/ame2.70222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 09.06.2026. Verfasst von Yansi Lyu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, P. R. China. Hauptthemen laut MEDLINE: Keratinocytes, Psoriasis, Autophagy, Inflammation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science, Technology and Innovation Commission of Shenzhen Municipality, Guangdong Provincial Enterprise Joint Fund - General Program, HaiYa Young Scientist Foundation of Shenzhen University General Hospital.
Abstract (Originalsprache)
Background
Psoriasis is an immune‐driven dermatosis marked by keratinocyte hyperproliferation. GS‐9620, a TLR7 agonist, previously mitigated EV71‐triggered inflammation in mice; here we probe its anti‐psoriatic potential and mechanisms.
Methods
IMQ‐induced psoriasis‐like mice were treated with GS‐9620 or MTX; severity was tracked by PASI and histology. Skin/spleen cytokines (IL‐1β, IL‐6, IL‐18, HMGB1, TNF‐α) were quantified via ELISA; immune subsets were quantified by flow cytometry. Autophagy proteins (ATG5/12/16 L1) and NLRP3 were assessed by IHC/Western blot. In vitro, M5‐stimulated primary keratinocytes were treated with GS‐9620 ± autophagy modulators, followed by cytokine and protein analyses.
Results
GS‐9620 markedly reduced erythema, scaling and epidermal thickness, lowered skin and systemic cytokines, and decreased splenic CD3 + /CD4 + IL‐17A + cells. It restored ATG5/12/16 L1 expression while suppressing NLRP3 both in lesions and in M5‐stimulated keratinocytes, leading to diminished IL‐1β, IL‐6, IL‐18, HMGB1 and TNF‐α release.
Conclusions
GS‐9620 alleviates psoriasis by enhancing autophagy and dampening NLRP3‐mediated inflammation, offering a promising therapeutic avenue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, P. R. China.
- Department of Immunology, Shenzhen University Medical School, Shenzhen, Guangdong, P. R. China.
- Department of Pathology, Affiliated Hospital of Hebei University, Baoding, Hebei, P. R. China.
- Department of Dermatology, Hainan Hospital of PLA General Hospital, Sanya, Hainan, P. R. China.
- Department of Dermatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, P. R. China.
- Department of Dermatology, Shenzhen Nanshan People's Hospital, Shenzhen, Guangdong, P. R. China.
ORCID-Profile: Qian Zhang
Förderung
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Guangdong Provincial Enterprise Joint Fund - General Program
- HaiYa Young Scientist Foundation of Shenzhen University General Hospital
- Shenzhen Medical Research Fund
Zitieren
APA
Lyu, Y., Zhou, W., Zhang, P., Lin, C., Wen, X., Zhao, Z., Zhang, G., Zhang, Q., & Chen, S. (2026). GS ‐9620 alleviates psoriasis‐like inflammation by regulating autophagy in keratinocytes. Animal Models and Experimental Medicine, 9(7), 1364-1372. https://doi.org/10.1002/ame2.70222
Vancouver
Lyu Y, Zhou W, Zhang P, Lin C, Wen X, Zhao Z, et al. GS ‐9620 alleviates psoriasis‐like inflammation by regulating autophagy in keratinocytes. Animal Models and Experimental Medicine. 2026;9(7):1364-1372. doi:10.1002/ame2.70222
BibTeX
@article{Lyu2026,
author = {Lyu, Yansi and Zhou, Wei and Zhang, Pei and Lin, Chen and Wen, Xin and Zhao, Zigang and Zhang, Guoqiang and Zhang, Qian and Chen, Si},
title = {GS ‐9620 alleviates psoriasis‐like inflammation by regulating autophagy in keratinocytes},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {7},
pages = {1364--1372},
doi = {10.1002/ame2.70222}
}
EUVIMED